Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Was the late declaration of 100k shares sold at 14.34 actually a sale or a purchase? Previous transaction at 14.26 was a sale with price of 72p. Normally a significantly larger sale a few mins late would go for a lot less than 72p not higher at 73p. Or have I missed something really simple?
I think there has been a bit of a woopsie here. I have been reading Mr Zenkers occasional posts and I understand that there are loads of A partners lining up to sign for lots and lots of munny. So obviously all this stuff about having to raise money just to get through to Q3 must be a silly mistake.
If you are not on corticosteroids you are better off taking Traumakine. but if, like the majority, you are on corticosteroids you are better of taking the placebo.
MR for Traumakine alone is 10.6% versus 14.8% placebo alone. MR for Traumakine plus corticosteroids is 39.7%; MR placebo plus corticosteroids is 27.6%.
Is 10.6% a statistically significant improvement over 14.8%?
Dibs, if you can hold your nerve over RENE then this one should be a doddle. There's just a lot of uncertainty here - we don't know when the validation batches will be manufactured, how long the testing will take and when eventually CE marking can be applied. And will we get another kick like ambient temperature problems. But even RENE picked up this morning so there is always hope........
Probably safest to hang on until Olav's promised "watch this space" for Q2 - the phase 3 stroke trial discussion results - and then try to sell on any price increase before it drops again. Like many, I live in hope, but I have been wary since MH's massive share dump in February last year.